9-methylstreptimidone has been researched along with Benign Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, Y; Matsui, C; Nishiyama, S; Obata, R; Tachibana, M; Umezawa, K | 1 |
Umezawa, K | 1 |
1 review(s) available for 9-methylstreptimidone and Benign Neoplasms
Article | Year |
---|---|
[Screening of bioactive metabolites that suppress inflammation].
Topics: Animals; Anti-Inflammatory Agents; Benzamides; Biological Products; Cell Differentiation; Cyclohexanones; Depsipeptides; Drug Design; Drug Evaluation, Preclinical; Inflammation; Inflammation Mediators; Lipopolysaccharides; Neoplasms; NF-kappa B; Osteoclasts; Piperidones; Signal Transduction | 2007 |
1 other study(ies) available for 9-methylstreptimidone and Benign Neoplasms
Article | Year |
---|---|
Synthesis and biological evaluation on novel analogs of 9-methylstreptimidone, an inhibitor of NF-kappaB.
Topics: Animals; Antioxidants; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Jurkat Cells; Lipopolysaccharides; Mice; Models, Chemical; Neoplasms; NF-kappa B; Nitric Oxide; Piperidones | 2009 |